PR55α Subunit of Protein Phosphatase 2A Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signaling

Cancer Research
Ashley L HeinY Yan

Abstract

The protein phosphatase 2 (PP2A) holoenzyme consists of a catalytic subunit, a scaffold subunit, and a regulatory subunit. Based on loss-of-function analysis using PP2A catalytic inhibitors or inhibition via tumor viral antigens, limited studies suggest that PP2A is a putative tumor suppressor. However, PP2A has also been shown to facilitate the activation of oncogenic signaling pathways when associated with specific regulatory subunits. In this study, we investigated the possible oncogenic role of PP2A in pancreatic cancer. We found a striking increase in the expression of PR55α (PPP2R2A), a PP2A regulatory subunit, in pancreatic cancer cells compared with normal pancreatic epithelial cells. Consistently, PR55α expression was markedly elevated in pancreatic ductal adenocarcinoma tissues compared with adjacent normal pancreatic tissues (P < 0.0001) and correlated with poor survival of pancreatic cancer patients (P < 0.0003). RNAi-mediated depletion of PR55α in pancreatic cancer cell lines resulted in diminished phosphorylation of both AKT and ERK1/2 (MAPK3/1) and decreased protein levels of β-catenin (CTNNB1). Accordingly, pancreatic cancer cells with reduced PR55α expression exhibited significantly impaired properties of trans...Continue Reading

References

Dec 2, 1999·Genes & Development·S R DattaM E Greenberg
Apr 12, 2001·The Journal of Biological Chemistry·H YamamotoA Kikuchi
May 2, 2002·Molecular Cell·Koji OkamotoCarol Prives
Dec 11, 2002·The European Journal of Neuroscience·Karsten SchmidtJürgen Götz
Feb 20, 2004·Development·Ruchi BajpaiL S Shashidhara
Mar 27, 2004·Cell Cycle·William C Hahn
May 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gennaro GaliziaCarlo Pignatelli
Jun 1, 2005·Laboratory Investigation; a Journal of Technical Methods and Pathology·Kwang M LeeMichel M Ouellette
Oct 22, 2005·The Journal of Biological Chemistry·Deanna G AdamsBrian E Wadzinski
Oct 31, 2006·Cellular and Molecular Life Sciences : CMLS·J-M Sontag, E Sontag
Feb 23, 2008·Trends in Biochemical Sciences·Veerle JanssensJozef Goris
Jul 1, 2008·Biochimica Et Biophysica Acta·Pieter J A EichhornRené Bernards
Nov 13, 2008·Cytotechnology·Kwang M LeeMichel M Ouellette
Jul 22, 2009·Developmental Cell·Bryan T MacDonaldXi He
Dec 31, 2010·Current Protein & Peptide Science·Sunanda Basu
Jul 8, 2011·World Journal of Gastroenterology : WJG·Miroslav ZavoralMarek Minarik
Jul 23, 2011·Genes & Cancer·Inbal Wortzel, Rony Seger
Jul 19, 2012·Journal of Surgical Oncology·Anne M Macgregor-Das, Christine A Iacobuzio-Donahue
Mar 5, 2013·Cancer Letters·Parthasarathy SeshacharyuluSurinder K Batra
Jun 1, 2013·Molecular Cancer Research : MCR·Yumiko NobumoriXuan Liu
Sep 26, 2015·International Journal of Molecular Sciences·Seraina Faes, Olivier Dormond

❮ Previous
Next ❯

Citations

Mar 3, 2018·Genes·Joshua J Thompson, Christopher S Williams
Mar 15, 2018·Nature Communications·Lingdi ZhangHeide L Ford
Aug 9, 2020·Pigment Cell & Melanoma Research·Eirini ChristodoulouRemco van Doorn
May 5, 2018·Cellular and Molecular Life Sciences : CMLS·Goutham NarlaChristopher B Ryder
Dec 18, 2018·Frontiers in Cell and Developmental Biology·Kamila Marzec, Andrew Burgess
Oct 13, 2019·Apoptosis : an International Journal on Programmed Cell Death·Yan XiongQifa Ye
Sep 2, 2020·Cancers·Sahar Sarmasti EmamiXiaolong Yang
Mar 22, 2019·Frontiers in Cell and Developmental Biology·Diana SchuhmacherEstelle Sontag
Mar 24, 2020·British Journal of Cancer·Rohitesh GuptaMoorthy P Ponnusamy
Nov 12, 2020·Cancer Communications·Zhenye TangJinfang Zhang
Jun 6, 2019·Molecular Cancer Research : MCR·Erika ParasidoChris Albanese
Dec 4, 2020·Biomolecules·Perrine Goguet-RubioAnna Castro
Dec 16, 2019·RSC Medicinal Chemistry·Martin DomXaveer Van Ostade
Jun 23, 2021·Journal of Medicinal Chemistry·Qiuyue ZhangLei Wang
Jul 3, 2021·International Journal of Molecular Sciences·Karlis VilksEdgars Liepinsh
Jul 3, 2021·Cancers·Jean-Paul BryantYeshavanth Kumar Banasavadi-Siddegowda
Sep 21, 2020·Biochimica Et Biophysica Acta. Molecular Cell Research·Renjie CuiJin Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.